Recent research points to that 4FMA, a synthetic copyright compound, might hold promising potential for therapeutic applications. While still in its developmental phase, studies have revealed that 4FMA can evoke intense copyright experiences, potentially rivaling those of more recognized psychedelics like LSD and copyright. Pioneers are currently